Neuberger Berman Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 187,806 shares of ARWR stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

187,806

Holding current value

$3.69 Million

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $386,406 - $589,588	19,959 Added 11.89%	187,806 $3.64 Million
Q4 2023 Nov 14, 2024	BUY	$21.2 - $31.03 $3.56 Million - $5.21 Million	167,847 New	167,847 $5.14 Million
Q4 2023 Feb 09, 2024	BUY	$21.2 - $31.03 $821,987 - $1.2 Million	38,773 Added 30.04%	167,847 $5.14 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $2.49 Million - $3.42 Million	-94,852 Reduced 42.36%	129,074 $3.47 Million
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $560,162 - $921,284	-22,264 Reduced 9.04%	223,926 $7.99 Million
Q1 2023 May 12, 2023	BUY	$23.68 - $38.51 $927,000 - $1.51 Million	39,147 Added 18.91%	246,190 $6.25 Million
Q4 2022 Feb 13, 2023	SELL	$28.0 - $40.56 $1.44 Million - $2.09 Million	-51,444 Reduced 19.9%	207,043 $8.4 Million
Q3 2022 Nov 15, 2022	BUY	$29.63 - $48.31 $294,374 - $479,959	9,935 Added 4.0%	258,487 $8.54 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $262,782 - $478,568	-9,456 Reduced 3.67%	248,552 $8.75 Million
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $620,013 - $1.09 Million	-15,649 Reduced 5.72%	258,008 $11.6 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $592,576 - $841,684	-10,201 Reduced 3.59%	273,657 $17.4 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $4.04 Million - $5.88 Million	69,178 Added 32.22%	283,858 $17.2 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $1.86 Million - $2.71 Million	-30,000 Reduced 12.26%	214,680 $17.2 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $3.39 Million - $5 Million	55,214 Added 29.14%	244,680 $15.9 Million
Q4 2020 Feb 10, 2021	BUY	$43.82 - $85.37 $2.5 Million - $4.88 Million	57,161 Added 43.2%	189,466 $14.2 Million
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $1.68 Million - $2.59 Million	50,609 Added 61.95%	132,305 $5.7 Million
Q2 2020 Aug 13, 2020	BUY	$26.12 - $43.27 $2.13 Million - $3.53 Million	81,696 New	81,696 $3.46 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Arrowhead Pharmaceuticals, Inc. Transaction History